Generic for Arcoxia, COX-2 anti-inflammatory analgesic is expected to be released soon. As the PMS ended on the 22nd of last month, it was confirmed that the generic company received the application on the 23rd, the next day.

Since generic companies have already confirmed patent avoidance, they are expected to market their products as soon as they go through approval and reimbursed procedures.

According to the MFDS on the 3rd, generic companies for Arcoxia (Etoricoxib) received applications on the 23rd. This drug is used to relieve symptoms or signs of osteoarthritis (degenerative arthritis).

MSD Korea's Arcoxia obtained a domestic approval on December 23, 2014. The MFDS